Lockheed Martin Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-391,100
Closed -$9.97M 114
2025
Q3
$9.97M Buy
391,100
+318,300
+437% +$7.86M 0.37% 55
2025
Q2
$1.76M Buy
+72,800
New +$1.7M 0.06% 102
2020
Q2
Sell
-226,198
Closed -$7M 73
2020
Q1
$7M Sell
226,198
-409,268
-64% -$13.9M 0.48% 44
2019
Q4
$23.6M Buy
635,466
+202,715
+47% +$7.22M 1.25% 16
2019
Q3
$14.8M Buy
432,751
+11,678
+3% +$425K 0.94% 17
2019
Q2
$17.3M Buy
421,073
+141,236
+50% +$5.61M 0.78% 28
2019
Q1
$11.3M Buy
+279,837
New +$11.2M 0.52% 30
2018
Q2
Sell
-18,972
Closed -$639K 119
2018
Q1
$639K Buy
+18,972
New +$652K 0.03% 106
2017
Q2
Sell
-143,397
Closed -$4.65M 138
2017
Q1
$4.65M Buy
143,397
+112,778
+368% +$3.56M 0.26% 55
2016
Q4
$944K Buy
+30,619
New +$935K 0.08% 99
2016
Q1
Sell
-25,823
Closed -$791K 97
2015
Q4
$791K Sell
25,823
-126,480
-83% -$3.98M 0.07% 66
2015
Q3
$4.54M Hold
152,303
0.51% 30
2015
Q2
$4.84M Buy
152,303
+63,240
+71% +$2.06M 0.24% 45
2015
Q1
$2.94M Buy
89,063
+37,417
+72% +$1.19M 0.14% 63
2014
Q4
$1.53M Hold
51,646
0.07% 73
2014
Q3
$1.45M Sell
51,646
-90,117
-64% -$2.53M 0.07% 83
2014
Q2
$3.99M Sell
141,763
-548,080
-79% -$15.6M 0.18% 50
2014
Q1
$21M Buy
689,843
+626,603
+991% +$18.7M 1.08% 20
2013
Q4
$1.84M Sell
63,240
-63,240
-50% -$1.84M 0.1% 81
2013
Q3
$3.45M Buy
+126,480
New +$3.44M 0.2% 61

Other funds holding PFE

Lockheed Martin Investment Management's PFE Position: Q4 2025 in Review

Lockheed Martin Investment Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 391,100 shares — an estimated $9.97M sold.

Lockheed Martin Investment Management first reported a position in PFE in Q3 2013 and held it in 20 quarters. The position peaked at $23.6M in Q4 2019. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Lockheed Martin Investment Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 391,100 Pfizer shares in Q4 2025, an estimated $9.97M.
  • Lockheed Martin Investment Management first reported a position in Pfizer in Q3 2013 and held it in 20 quarters.
  • Lockheed Martin Investment Management's Pfizer position peaked at $23.6M in Q4 2019.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Lockheed Martin Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.